Prevalence, association, and prognostic significance of polypharmacy and sarcopenia in patients with liver cirrhosis.

Tatsunori HanaiKayoko NishimuraTakao MiwaToshihide MaedaKenji ImaiAtsushi SuetsuguKoji TakaiMasahito Shimizu

Published in: JGH open : an open access journal of gastroenterology and hepatology (2023)

Polypharmacy and sarcopenia are interrelated and associated with poor prognosis in patients with cirrhosis. Further large, prospective, population-based studies are required to validate these findings.

Keyphrases

poor prognosis
long non coding rna
skeletal muscle
adverse drug
risk factors
community dwelling
case control
emergency department